Markets:

Overview

News

Currencies

International

Treasuries

Artivion, Inc. Common Stock (NY:AORT)

44.60 -0.45 (-1.00%)

Streaming Delayed Price Updated: 2:45 PM EST, Jan 8, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Artivion, Inc. Common Stock

< Previous 1 2 3 4 Next >

Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q4 Earnings: ICU Medical (NASDAQ:ICUI) Best of the Bunch

March 25, 2025

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the medical devices & supplies - cardiology, neurology, vascular stocks, including ICU Medical (NASDAQ:ICUI) and its peers.

Via StockStory

ICU Medical (ICUI) Q4 Earnings Report Preview: What To Look For

February 26, 2025

Medical device company ICU Medical (NASDAQ:ICUI) will be reporting results tomorrow after market close. Here’s what you need to know.

Via StockStory

Artivion (AORT) Stock Trades Down, Here Is Why

February 25, 2025

Shares of medical device company Artivion (NYSE:AORT) fell 11.2% in the morning session after the company reported weak fourth-quarter 2024 results, as both revenue and EPS missed Wall Street's...

Via StockStory

Breaking Down Artivion: 4 Analysts Share Their Views ↗

February 25, 2025

Via Benzinga

Where Artivion Stands With Analysts ↗

January 28, 2025

Via Benzinga

In-Depth Examination Of 6 Analyst Recommendations For Artivion ↗

December 10, 2024

Via Benzinga

Where Artivion Stands With Analysts ↗

November 08, 2024

Via Benzinga

Assessing Artivion: Insights From 6 Financial Analysts ↗

October 23, 2024

Via Benzinga

Artivion (NYSE:AORT) Misses Q4 Sales Targets

February 24, 2025

Medical device company Artivion (NYSE:AORT) missed Wall Street’s revenue expectations in Q4 CY2024 as sales rose 3.9% year on year to $97.31 million. The company’s full-year revenue guidance of $427.5...

Via StockStory

Earnings Scheduled For February 24, 2025 ↗

February 24, 2025

Via Benzinga

The Latest Analyst Ratings For Artivion ↗

October 23, 2024

Via Benzinga

Analyst Scoreboard: 5 Ratings For Artivion ↗

September 13, 2024

Via Benzinga

Artivion (AORT) Q4 Earnings: What To Expect

February 23, 2025

Medical device company Artivion (NYSE:AORT) will be reporting results tomorrow after the bell. Here’s what you need to know.

Via StockStory

Artivion (NYSE:AORT) Q3 Earnings: Leading The Medical Devices & Supplies - Cardiology, Neurology, Vascular Pack

February 14, 2025

Wrapping up Q3 earnings, we look at the numbers and key takeaways for the medical devices & supplies - cardiology, neurology, vascular stocks, including Artivion (NYSE:AORT) and its peers.

Via StockStory

Unpacking Q3 Earnings: ICU Medical (NASDAQ:ICUI) In The Context Of Other Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks

February 14, 2025

As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the medical devices & supplies - cardiology, neurology, vascular industry, including...

Via StockStory

Spotting Winners: Penumbra (NYSE:PEN) And Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks In Q3

February 13, 2025

Looking back on medical devices & supplies - cardiology, neurology, vascular stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including Penumbra (NYSE:PEN) and its peers.

Via StockStory

A Glimpse Into The Expert Outlook On Artivion Through 4 Analysts ↗

July 02, 2024

Via Benzinga

Breaking Down Artivion: 4 Analysts Share Their Views ↗

May 07, 2024

Via Benzinga

Earnings Scheduled For February 15, 2024 ↗

February 15, 2024

Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earnings at $0.10 per share on revenue of $188.59 million.

Via Benzinga

Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q3 Teardown: Merit Medical Systems (NASDAQ:MMSI) Vs The Rest

February 13, 2025

As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the medical devices & supplies - cardiology, neurology, vascular industry, including Merit Medical Systems...

Via StockStory

AORT Stock Earnings: Artivion Beats EPS, Beats Revenue for Q2 2024 ↗

August 08, 2024

AORT stock results show that Artivion beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

Via InvestorPlace

3 Earnings All-Stars With More Room to Run ↗

July 03, 2024

Travelers, Seagate Technology and Artivion are top earnings outperformers poised for further growth and significant returns.

Via InvestorPlace

Tempur Sealy Posts Upbeat Earnings, Joins FibroGen, Coca-Cola Consolidated, Fabrinet And Other Big Stocks Moving Higher On Tuesday ↗

May 07, 2024

Via Benzinga

Artivion's Earnings: A Preview ↗

February 14, 2024

Via Benzinga

Why Beyond Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

May 07, 2024

Via Benzinga

AORT Stock Earnings: Artivion Beats EPS, Beats Revenue for Q1 2024 ↗

May 06, 2024

AORT stock results show that Artivion beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

February 19, 2024

Via Benzinga

Why DoorDash Shares Are Trading Lower By Around 12%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

February 16, 2024

Shares of DoorDash, Inc. (NASDAQ: DASH) fell sharply in today’s session as the company reported mixed financial results for its fourth quarter.

Via Benzinga

Applied Materials Posts Upbeat Earnings, Joins Texas Roadhouse, Vulcan Materials And Other Big Stocks Moving Higher On Friday ↗

February 16, 2024

U.S. stocks were lower, with the Dow Jones index falling more than 100 points on Friday.

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

February 16, 2024

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.